Literature DB >> 33840413

[Immune dysregulation syndrome caused by STAT3 gene mutation: a complicated case study].

An-Qi Yao1, Ke-Ke Chen1, Xiang-Ling He1, Xin Tian1.   

Abstract

A boy, aged 4 years and 6 months, had disease onset of fever, cough, pale complexion, and weakness, with hepatosplenomegaly, lymphadenectasis, and pancytopenia. He had been having repeated respiratory and digestive tract infections. Gene detection showed a pathogenic heterozygous mutation, c.C2147 > T(p.T716M), in the STAT3 gene. The boy was thus diagnosed with immune dysregulation syndrome. Anti-infective therapy and irregular corticosteroid therapy had an unsatisfactory effect in the early stage, but the symptoms improved after regular corticosteroid therapy. This article reported the case of immune dysregulation syndrome caused by STAT3 gene mutation and summarized the epidemiology, clinical features, diagnosis, and treatment of this disease, which can provide a reference for early diagnosis, treatment, and future studies of this disease.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33840413      PMCID: PMC8050543     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  13 in total

1.  STAT3: too much may be worse than not enough!

Authors:  Elie Haddad
Journal:  Blood       Date:  2015-01-22       Impact factor: 22.113

2.  [Clinical and immunological analysis of the patient with autoimmunity due to germline STAT3 gain-of-function mutation].

Authors:  Y Ding; Y Zhang; Y P Wang; H Y Zhao; X M Chen; X H Xue; X M Bai; Y F An; Z Y Zhang; X M Tang; X D Zhao
Journal:  Zhonghua Er Ke Za Zhi       Date:  2017-01-02

3.  Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review.

Authors:  Alexandre Fabre; Sarah Marchal; Vincent Barlogis; Bernard Mari; Pascal Barbry; Pierre-Simon Rohrlich; Lisa R Forbes; Tiphanie P Vogel; Lisa Giovannini-Chami
Journal:  J Allergy Clin Immunol Pract       Date:  2019-02-27

4.  Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.

Authors:  Joshua D Milner; Tiphanie P Vogel; Lisa Forbes; Chi A Ma; Asbjørg Stray-Pedersen; Julie E Niemela; Jonathan J Lyons; Karin R Engelhardt; Yu Zhang; Nermina Topcagic; Elisha D O Roberson; Helen Matthews; James W Verbsky; Trivikram Dasu; Alexander Vargas-Hernandez; Nidhy Varghese; Kenneth L McClain; Lina B Karam; Karen Nahmod; George Makedonas; Emily M Mace; Hanne S Sorte; Gøri Perminow; V Koneti Rao; Michael P O'Connell; Susan Price; Helen C Su; Morgan Butrick; Joshua McElwee; Jason D Hughes; Joseph Willet; David Swan; Yaobo Xu; Mauro Santibanez-Koref; Voytek Slowik; Darrell L Dinwiddie; Christina E Ciaccio; Carol J Saunders; Seth Septer; Stephen F Kingsmore; Andrew J White; Andrew J Cant; Sophie Hambleton; Megan A Cooper
Journal:  Blood       Date:  2014-10-30       Impact factor: 22.113

5.  Short Stature in a Boy with Multiple Early-Onset Autoimmune Conditions due to a STAT3 Activating Mutation: Could Intracellular Growth Hormone Signalling Be Compromised?
.

Authors:  Hana Sediva; Petra Dusatkova; Veronika Kanderova; Barbora Obermannova; Jana Kayserova; Lucie Sramkova; Dana Zemkova; Lenka Elblova; Michal Svaton; Radana Zachova; Stanislava Kolouskova; Eva Fronkova; Zdenek Sumnik; Anna Sediva; Jan Lebl; Stepanka Pruhova
Journal:  Horm Res Paediatr       Date:  2017-03-02       Impact factor: 2.852

6.  Partial growth hormone insensitivity and dysregulatory immune disease associated with de novo germline activating STAT3 mutations.

Authors:  Mariana Gutiérrez; Paula Scaglia; Ana Keselman; Lucía Martucci; Liliana Karabatas; Sabina Domené; Ayelen Martin; Patricia Pennisi; Miguel Blanco; Nora Sanguineti; Liliana Bezrodnik; Daniela Di Giovanni; María Soledad Caldirola; María Esnaola Azcoiti; María Isabel Gaillard; Lee A Denson; Kejian Zhang; Ammar Husami; Nana-Hawa Yayah Jones; Vivian Hwa; Santiago Revale; Martín Vázquez; Héctor Jasper; Ashish Kumar; Horacio Domené
Journal:  Mol Cell Endocrinol       Date:  2018-02-03       Impact factor: 4.102

7.  Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations.

Authors:  Lisa R Forbes; Tiphanie P Vogel; Megan A Cooper; Johana Castro-Wagner; Edith Schussler; Katja G Weinacht; Ashley S Plant; Helen C Su; Eric J Allenspach; Mary Slatter; Mario Abinun; Desa Lilic; Charlotte Cunningham-Rundles; Olive Eckstein; Peter Olbrich; R Paul Guillerman; Niraj C Patel; Yesim Y Demirdag; Christa Zerbe; Alexandra F Freeman; Steven M Holland; Paul Szabolcs; Andrew Gennery; Troy R Torgerson; Joshua D Milner; Jennifer W Leiding
Journal:  J Allergy Clin Immunol       Date:  2018-08-06       Impact factor: 10.793

8.  Up, Down, and All Around: Diagnosis and Treatment of Novel STAT3 Variant.

Authors:  Michael Alexander Weinreich; Tiphanie P Vogel; V Koneti Rao; Joshua D Milner
Journal:  Front Pediatr       Date:  2017-03-13       Impact factor: 3.418

9.  Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease.

Authors:  Sarah E Flanagan; Emma Haapaniemi; Mark A Russell; Richard Caswell; Hana Lango Allen; Elisa De Franco; Timothy J McDonald; Hanna Rajala; Anita Ramelius; John Barton; Kaarina Heiskanen; Tarja Heiskanen-Kosma; Merja Kajosaari; Nuala P Murphy; Tatjana Milenkovic; Mikko Seppänen; Åke Lernmark; Satu Mustjoki; Timo Otonkoski; Juha Kere; Noel G Morgan; Sian Ellard; Andrew T Hattersley
Journal:  Nat Genet       Date:  2014-07-20       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.